BioArctic
Biopharmaceutical firm developing antibody therapies for neurodegenerative diseases.
BIOA | ST
Overview
Corporate Details
- ISIN(s):
- SE0010323303 (+1 more)
- LEI:
- 549300Y0OI2WVUNHLC33
- Country:
- Sweden
- Address:
- Warfvinges väg 35, 112 51 Stockholm
- Website:
- https://www.bioarctic.se/en/
Description
BioArctic is a research-intensive biopharmaceutical company focused on developing disease-modifying treatments, biomarkers, and diagnostics for neurodegenerative diseases. The company's core strategy is based on its proprietary antibody technology, which develops unique treatments that target the misfolded and aggregated proteins considered to be the underlying cause of disorders such as Alzheimer's and Parkinson's disease. Through strategic partnerships with global pharmaceutical companies, BioArctic advances its innovative therapies from research through clinical development and commercialization, aiming to address significant unmet medical needs in neurology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-02-20 08:01 | English | 564.2 KB | |||
| 2018-02-05 17:30 |
Invitation to presentation of BioArctic’s Full Year Report 2017 on February 20,…
|
English | 499.9 KB | ||
| 2018-02-05 17:30 |
Inbjudan till presentation av BioArctics bokslutskommuniké 2017 den 20 februari…
|
Swedish | 498.4 KB | ||
| 2018-02-02 08:00 |
BioArctic får patentskydd i USA för en metod med en medicinteknisk produkt för …
|
Swedish | 497.3 KB | ||
| 2018-02-02 08:00 |
BioArctic receives US patent protection for a method with a medical device for …
|
English | 497.8 KB | ||
| 2017-12-21 13:00 |
BioArctic announces that the Phase 2b study of BAN2401 in early Alzheimer´s Dis…
|
English | 574.1 KB | ||
| 2017-12-21 13:00 |
BioArctic meddelar att Fas 2b studien med BAN2401 i patienter med tidig Alzheim…
|
Swedish | 574.1 KB | ||
| 2017-11-09 13:30 |
BioArctic presents Nomination Committee and publishes financial calendar 2018
|
English | 294.6 KB | ||
| 2017-11-09 13:30 |
BioArctic presenterar valberedning och offentliggör finansiell kalender 2018
|
Swedish | 292.0 KB | ||
| 2017-11-08 08:01 | Swedish | 729.3 KB | |||
| 2017-11-08 08:01 | English | 804.8 KB | |||
| 2017-11-06 20:00 |
UTNYTTJANDE AV ÖVERTILLDELNINGSOPTION OCH AVSLUTANDE AV STABILISERINGSPERIOD
|
Swedish | 294.7 KB | ||
| 2017-11-01 13:41 | English | 34.1 KB | |||
| 2017-10-31 18:00 |
Ändring av antalet aktier och röster i BioArctic AB (publ)
|
Swedish | 288.2 KB | ||
| 2017-10-31 18:00 |
Change in the number of shares and votes in BioArctic AB (publ)
|
English | 288.2 KB |
Automate Your Workflow. Get a real-time feed of all BioArctic filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioArctic
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioArctic via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-13 | Gunilla Osswald | Other | Sell | 40,000 | 8,821,200.00 SEK |
| 2025-02-13 | Gunilla Osswald | Other | Other | 40,000 | 3,344,000.00 SEK |
| 2025-02-13 | Sten Mikael Moge | Other | Sell | 6,000 | 1,323,180.00 SEK |
| 2025-02-13 | Sten Mikael Moge | Other | Other | 6,000 | 501,600.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Sell | 1,500 | 330,795.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Other | 2,500 | 209,000.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Other | 1,500 | 125,400.00 SEK |
| 2025-01-10 | Mikael Smedeby | Other | Buy | 730 | 148,920.00 SEK |
| 2024-12-19 | Oskar Bosson | Other | Sell | 2,000 | 446,000.00 SEK |
| 2024-12-19 | Oskar Bosson | Other | Sell | 871 | 195,626.60 SEK |
Peer Companies
